相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug screening of rhodanine derivatives for antibacterial activity
Suresh Maddila et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
SYBA: Bayesian estimation of synthetic accessibility of organic compounds
Milan Vorsilak et al.
JOURNAL OF CHEMINFORMATICS (2020)
Identification of 4-diphenylamino 3-iodo coumarin as a potent inhibitor of DNA gyrase B of S. aureus
Chennakkandathil Sareena et al.
MICROBIAL PATHOGENESIS (2020)
Screening an Established Natural Product Library Identifies Secondary Metabolites That Potentiate Conventional Antibiotics
Anne E. Mattingly et al.
ACS INFECTIOUS DISEASES (2020)
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors
Davide Benedetto Tiz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion
Benjamin D. Bax et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
In Vitro and In Vivo Activities of DS86760016, a Novel Leucyl-tRNA Synthetase Inhibitor for Gram-Negative Pathogens
Kedar P. Purnapatre et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity
Martina Durcik et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase
Katherine A. Hurley et al.
MEDCHEMCOMM (2017)
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB
Michael F. Mesleh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV
Victoria J. Savage et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates
Ahmed AbdelKhalek et al.
PLOS ONE (2016)
Insights into the Mechanism of Inhibition of Novel Bacterial Topoisomerase Inhibitors from Characterization of Resistant Mutants of Staphylococcus aureus
Sushmita D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines
Malela M. Werner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA)
Iveta Zadrazilova et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
Gregory S. Bisacchi et al.
ACS INFECTIOUS DISEASES (2015)
Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis
Shahul P. Hameed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Computer-aided identification of novel 3,5-substituted rhodanine derivatives with activity against Staphylococcus aureus DNA gyrase
Malela M. Werner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Substandard drugs: a potential crisis for public health
Atholl Johnston et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Prospects for Developing New Antibacterials Targeting Bacterial Type IIA Topoisomerases
Tihomir Tomašić et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Modeling a Crowdsourced Definition of Molecular Complexity
Robert P. Sheridan et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization
Gregory S. Basarab et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds
Bhargav A. Patel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation
Tihomir Tomasic et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis
Sidharth Chopra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Structure-Based Discovery of Substituted 4,5′-Bithiazoles as Novel DNA Gyrase Inhibitors
Matjaz Brvar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
Thomas Mendgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Frederic Collin et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
5-Hydroxymethylfurfural (HMF) as a building block platform: Biological properties, synthesis and synthetic applications
Andreia A. Rosatella et al.
GREEN CHEMISTRY (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
5-Benzylidenethiazolidin-4-ones as Multitarget Inhibitors of Bacterial Mur Ligases
Tihomir Tomasic et al.
CHEMMEDCHEM (2010)
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains
Diane Hardej et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Rhodanine as a Privileged Scaffold in Drug Discovery
T. Tomasic et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
S. Kohno et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups
Michael D. Huband et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Antimicrobial resistance in gram-positive bacteria
Louis B. Rice
AMERICAN JOURNAL OF INFECTION CONTROL (2006)
In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class
N Mani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Complex molecules: do they add value?
P Selzer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections
GA Pankey et al.
CLINICAL INFECTIOUS DISEASES (2004)
Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center
B Bozdogan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
LigBuilder: A multi-purpose program for structure-based drug design
RX Wang et al.
JOURNAL OF MOLECULAR MODELING (2000)
分享论文
